ORTHOFIX MEDICAL ($OFIX) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of $0.26 per share, beating estimates of -$0.32 by $0.58. The company also reported revenue of $218,600,000, missing estimates of $223,088,892 by $-4,488,892.
You can see Quiver Quantitative's $OFIX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ORTHOFIX MEDICAL Insider Trading Activity
ORTHOFIX MEDICAL insiders have traded $OFIX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $OFIX stock by insiders over the last 6 months:
- MASSIMO CALAFIORE (President & CEO) has made 0 purchases and 2 sales selling 19,397 shares for an estimated $300,955.
- JULIE ANDREWS (CFO) sold 4,873 shares for an estimated $70,073
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ORTHOFIX MEDICAL Hedge Fund Activity
We have seen 59 institutional investors add shares of ORTHOFIX MEDICAL stock to their portfolio, and 111 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JUNIPER INVESTMENT COMPANY, LLC added 663,278 shares (+23.3%) to their portfolio in Q4 2025, for an estimated $10,055,294
- ARMISTICE CAPITAL, LLC added 412,000 shares (+18.4%) to their portfolio in Q4 2025, for an estimated $6,245,920
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 261,147 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,823,192
- NUVEEN, LLC removed 203,230 shares (-38.0%) from their portfolio in Q4 2025, for an estimated $3,080,966
- DIMENSIONAL FUND ADVISORS LP removed 193,458 shares (-16.9%) from their portfolio in Q4 2025, for an estimated $2,932,823
- ROYAL BANK OF CANADA removed 187,474 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $2,842,105
- PHILOSOPHY CAPITAL MANAGEMENT LLC added 131,586 shares (+14.9%) to their portfolio in Q4 2025, for an estimated $1,994,843
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ORTHOFIX MEDICAL Analyst Ratings
Wall Street analysts have issued reports on $OFIX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 10/28/2025
- Barrington Research issued a "Outperform" rating on 10/23/2025
To track analyst ratings and price targets for ORTHOFIX MEDICAL, check out Quiver Quantitative's $OFIX forecast page.
ORTHOFIX MEDICAL Price Targets
Multiple analysts have issued price targets for $OFIX recently. We have seen 3 analysts offer price targets for $OFIX in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Michael Petusky from Barrington Research set a target price of $18.0 on 02/17/2026
- Mathew Blackman from TD Cowen set a target price of $14.0 on 01/27/2026
- Thomas Stephan from Stifel set a target price of $22.0 on 10/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
